US Drug Recall Register
Class III · Low risk Terminated Initiated Jul 28, 2015 (11 years ago)

Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single dose…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Incorrect Expiration Date: The "11/06" expiration date printed on the tray (secondary packaging) is incorrect (it should be 11/2016)

What was recalled

Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single dose vial. Manufactured by Fresenius Kabi USA 2020 N Ruby Street, Melrose Park, IL 60160-1112 for Fresenius Kabi USA, 3 Corporate Dr Lake Zurich, IL 60047-8930. NDC 63323-614-01

Recalling firm
Fresenius Kabi USA, LLC
NDC code
63323-614-01
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1327-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all